Position in VRTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$934,349
+$121,200 QoQ
Shares Held
1,881
+3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#877
of 1,746 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Savvy Advisors, Inc. holds $15,531,812 across 11 Biotechnology names. VRTX ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VIR |
Vir Biotechnology, Inc.
|
1,040,665 | $10,604,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,185 | $1,362,434 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
45,194 | $1,162,389 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,881 | $934,349 | |
| 5 | INCY |
Incyte Corp
|
5,248 | $594,913 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,511 | $258,331 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
|
6,794 | $252,125 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
5,290 | $206,362 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $934,349 | 1,881 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $813,149 | 1,821 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $797,913 | 1,760 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $555,737 | 1,419 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $403,796 | 907 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $301,558 | 622 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||